December 2018 FDA Recall Drug by Results Rna, Llc
D-0360-2019 - Lack of Sterility Assurance and Incorrect/Undeclared excipient
This Class I drug recall was voluntarily initiated by Results Rna, Llc on December 14, 2018 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance and incorrect/undeclared excipient. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0360-2019
Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver
12-14-2018
12-26-2018
10,297 bottles
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Results RNA, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide within the United States
01-29-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4
Batch or Lot Expiration Information
Lot# All Lots